InsiderClue
← All stocks

Celularity Inc

CELU Net buying
CIK 0001752828 #4993 in the set updated 21 Sep 2026
Bought (120 mo)
$8.47M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
2 of 2 sales
Net
+$8.47M
+$8.47M against sales at will

By person

24 insiders · 16 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Lim Kok Thay
10% owner
$5.33M (1)
—
+$5.33M
36,634,474
—
$9.12M
—
Hariri Robert J
Chief Executive Officer
$3.14M (6)
—
+$3.14M
2,853,553
9.86%
$710.53K
—
Sorrento Therapeutics, Inc. entity
10% owner
—
— (2)
$0.00
5,050,427
17.45%
$1.26M
−75.3%
STARR INTERNATIONAL CO INC entity
10% owner
—
—
—
15,281,389
52.79%
$3.81M
+76.9%
Bloom Jay R
Director
—
—
—
1,761,253
6.08%
$438.55K
+6.0%
Kilcoyne Adrian
Chief Medical Officer
—
—
—
1,122,238
3.88%
$279.44K
—
SCULLEY JOHN
Director
—
—
—
1,004,660
3.47%
$250.16K
—
Kehler Dean C
Director
—
—
—
797,858
2.76%
$198.67K
+102.3%
Parks Diane L.
Director
—
—
—
520,021
1.80%
$129.49K
—
Diamandis Peter
Director
—
—
—
394,150
1.36%
$98.14K
—
Glover Bradley
See Remarks
—
—
—
351,192
1.21%
$87.45K
—
VON ESCHENBACH ANDREW C.
Director
—
—
—
336,066
1.16%
$83.68K
—
Ling Geoffrey M.D.
Director
—
—
—
256,026
0.8845%
$63.75K
—
Mazur Marc
Director
—
—
—
236,066
0.8155%
$58.78K
—
Smith Robin L
Director
—
—
—
236,066
0.8155%
$58.78K
—
LeVien Vincent
Director
—
—
—
153,847
0.5315%
$38.31K
—
GX Sponsor LLC entity
10% owner
—
—
—
100,000
0.3455%
$24.90K
—
BERMAN RICHARD J
Director
—
—
—
67,416
0.2329%
$16.79K
—
Jones Anne
Chief Business Officer
—
—
—
49,154
0.1698%
$12.24K
—
Haines John R
Senior Exec Vice President
—
—
—
30,179
0.1043%
$7.51K
—
Fletcher Kyle
See Remarks
—
—
—
21,085
0.0728%
$5.25K
—
Beers David C
Chief Financial Officer
—
—
—
18,201
0.0629%
$4.53K
—
Dunn Keary
See Remarks
—
—
—
16,405
0.0567%
$4.08K
—
Brigido Stephen
Pres., Functional Regeneration
—
—
—
9,474
0.0327%
$2.36K
—

Individual transactions

16
Insider
Date
Role
Action
Shares
Price
Amount
Lim Kok Thay
24 Jan 2025
10% owner
Exercised, kept indirect
652,981
$2.07
$1.35M
Lim Kok Thay
24 Jan 2025
10% owner
Exercised, kept indirect
535,274
$2.07
$1.11M
Lim Kok Thay
12 Jan 2024
10% owner
Buy indirect
21,410,983
$0.25
$5.33M
Sorrento Therapeutics, Inc.
5 Oct 2023
10% owner
Sell
6,307,158
—
no price
Hariri Robert J
5 Oct 2023
Chief Executive Officer
Buy
3,050,427
$0.16
$483.80K
Hariri Robert J
5 Oct 2023
Chief Executive Officer
Buy
6,307,158
$0.16
$1.00M
Sorrento Therapeutics, Inc.
29 Sep 2023
10% owner
Sell
9,064,539
—
no price
Hariri Robert J
29 Sep 2023
Chief Executive Officer
Buy
9,064,539
$0.17
$1.50M
Diamandis Peter
10 Feb 2023
Director
Exercised, kept
1,071,000
$0.28
$299.88K
Hariri Robert J
30 Nov 2022
Chief Executive Officer
Buy
10,000
$1.72
$17.18K
Hariri Robert J
29 Nov 2022
Chief Executive Officer
Buy
40,000
$1.71
$68.40K
Hariri Robert J
28 Nov 2022
Chief Executive Officer
Buy
40,000
$1.74
$69.60K
SCULLEY JOHN
26 Aug 2022
Director
Exercised, kept
768,594
$0.28
$215.21K
Hariri Robert J
24 Aug 2022
Chief Executive Officer
Exercised, kept
119,073
$2.87
$341.74K
STARR INTERNATIONAL CO INC
1 Mar 2022
10% owner
Exercised, kept indirect
6,640,694
$3.50
$23.24M
VON ESCHENBACH ANDREW C.
9 Nov 2021
Director
Exercised, kept
100,000
$0.28
$28.00K

What was left out

Form 4 filings counted 142
Amendments (4/A) skipped 9
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 2
Shares from compensation/vesting 99,082,041
History held since 16 Jul 2021